Latest news with #drugmanufacturing
ABC News
18-05-2025
- Business
- ABC News
What has caused Australia's medicine shortages in recent years?
Supply chain researcher Peter Coomber says Australia is not one of the most attractive markets to drug manufacturers.
Reuters
12-05-2025
- Business
- Reuters
Roche to invest $700 million in new drug manufacturing facility in North Carolina
May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in Holly Springs, North Carolina. The new facility will ultimately support Roche and its unit Genentech's future portfolio of next-generation obesity medicines and "this initial investment could expand in the future, based on business needs and the U.S. policy environment," Roche said in a statement. The project will add more than 400 manufacturing jobs when the site is operational. Roche in April said it would invest $50 billion in the United States over the next five years, creating more than 12,000 new jobs, in the latest massive investment by companies reacting to President Donald Trump's tariff policy. President Trump plans to sign an executive order on prescription drug pricing on Monday that aims to align the United States with what other countries pay, a move he said on social media would be a cut of 59%.
Reuters
09-05-2025
- Business
- Reuters
Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
May 9 (Reuters) - Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter. The buyout firm is in discussions with PCI's backers — Kohlberg & Co, Mubadala Investment Co and Partners Group Holding AG — about a deal for a majority stake of the Philadelphia-based drug services provider, the report said. A representative for PCI declined to comment. PCI is a contractor that does fill-finish work involving the filling and packaging of syringes and injection pens in sterile conditions for drugmakers. It also provides tools and services that help in research and development of new drugs. According to the report, Bain has reached out to a variety of potential co-investors, including sovereign wealth funds, about helping to finance the equity portion of a deal.
